Our Approach
msc isolation
We leverage MSCs as a cellular vaccine platform due to their unique plasticity, ease of isolation and expansion, as well as their ability to present multiple antigens simultaneously while maintaining favorable safety profiles. Our mandate is to leverage our robust platform to create prophylactic vaccines and immuno-therapies to fight multiple forms of cancer.
Reprogramming
We treat MSCs with specific drugs to reactivate silenced genes known to be expressed by cancer cells.
Cellular Vaccine
Reprogrammed MSCs can express multiple cancer antigens simultaneously, creating a polyvalent vaccine capable of triggering broad and more efficient anti-tumor immune responses compared to standard immunotherapies.
TECHNOLOGY
MSC
ISOLATION
Access to a defined Master Cell Bank (MSC).
Reprogramming
Treatment
Treat MSCs with a proprietary recipe to activate CTA gene transcription.
CTA
Expression
Robust induction of multiple Cancer-Testis Antigen (CTA) families.
Cellular Vaccine
Reprogrammed MSCs serve as living vaccines, presenting multiple CTAs to stimulate a diversified anti-tumor immune and therapeutic responses to a defined Master Cell Bank.
pipeline
